3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
14
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
42
Docetaxel
33
Paclitaxel
31
Tamoxifen
29
Doxorubicin
29
Trastuzumab
25
Radiotherapy
21
Epirubicin
16
Letrozole
15
Anastrozole
12
exemestane
11
Fluorouracil
11
Capecitabine
10
Bevacizumab
10
palbociclib
9
Immunohistochemistry
9
Fulvestrant
9
Filgrastim
9
Lapatinib
8
Zoledronic Acid
7
Methotrexate
7
Magnetic Resonance Spectroscopy
7
Gene Expression Profiling
7
pertuzumab
6
Triptorelin Pamoate
6
Taxes
6
Surgical Procedures, Operative
6
Microarray Analysis
6
Goserelin
6
Chemotherapy, Adjuvant
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Low-Level Light Therapy
×
Breast
×
Clear all
NCT06995443
2026-01-30
REGAIN
Centre Hospitalier de Valenciennes
Phase NA
Recruiting
200 enrolled